Literature DB >> 8831000

Tissue engineered bone-regeneration using degradable polymers: the formation of mineralized matrices.

C T Laurencin1, M A Attawia, H E Elgendy, K M Herbert.   

Abstract

In the development of 3-dimensional cell-polymer matrices for tissue engineering, the ability of osteoblast cells to maintain their phenotypic properties and form a mineralized matrix while seeded on the polymer surface is very important. Osteoblast cell differentiation and bone formation using rat calvaria cells were studied on the surface of a porous poly(lactide/glycolide)/hydroxyapatite (PLAGA/HA) 3-dimensional polymer matrix. Cell adhesion and proliferation were determined at 24 hr, 3, 7, 14, and 21 days. Cell attachment and proliferation were observed to increase throughout the first two weeks of the study, followed by a period of gradual plateauing of cell numbers. Environmental scanning electron microscopy demonstrated that cells grown on the surface of the 3-dimensional porous PLAGA/HA matrix retained their characteristic morphology and grew in a multi-layer fashion. Light microscopy observations of experiment cultures revealed active osteoblastic cells forming a characteristic mineralized matrix in the presence of beta-glycerophosphate as a phosphate donor. Mineralization did not occur in media either not supplemented with beta-glycerophosphate or when the matrix without cells was incubated with the reagents, indicating that the mineralization was due to the cells and not the HA in the matrix. These results suggest that the 3-dimensional PLAGA/HA matrix could provide a matrix for bone cell differentiation and mineralization in vitro and, therefore, may be a candidate as a synthetic implant for bone regeneration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831000     DOI: 10.1016/s8756-3282(96)00132-9

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  24 in total

1.  Bone tissue engineering in a rotating bioreactor using a microcarrier matrix system.

Authors:  E A Botchwey; S R Pollack; E M Levine; C T Laurencin
Journal:  J Biomed Mater Res       Date:  2001-05

2.  Collagen microcarrier spinner culture promotes osteoblast proliferation and synthesis of matrix proteins.

Authors:  Michael Overstreet; Afshin Sohrabi; Anna Polotsky; David S Hungerford; Carmelita G Frondoza
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 May-Jun       Impact factor: 2.416

Review 3.  Biomimetic materials for tissue engineering.

Authors:  Peter X Ma
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

Review 4.  [Bioreactors in tissue culture].

Authors:  A Haisch
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

5.  Analysis of OPLA scaffolds for bone engineering constructs using human jaw periosteal cells.

Authors:  Dorothea Alexander; Jürgen Hoffmann; Adelheid Munz; Björn Friedrich; Jürgen Geis-Gerstorfer; Siegmar Reinert
Journal:  J Mater Sci Mater Med       Date:  2007-12-25       Impact factor: 3.896

6.  A novel nanoparticle-enhanced photoacoustic stimulus for bone tissue engineering.

Authors:  Balaji Sitharaman; Pramod K Avti; Kenneth Schaefer; Yahfi Talukdar; Jon P Longtin
Journal:  Tissue Eng Part A       Date:  2011-05-06       Impact factor: 3.845

Review 7.  Biomaterials for Bone Regenerative Engineering.

Authors:  Xiaohua Yu; Xiaoyan Tang; Shalini V Gohil; Cato T Laurencin
Journal:  Adv Healthc Mater       Date:  2015-04-07       Impact factor: 9.933

Review 8.  Biocomposites and hybrid biomaterials based on calcium orthophosphates.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Jul-Sep

Review 9.  Nanostructured injectable cell microcarriers for tissue regeneration.

Authors:  Zhanpeng Zhang; Thomas W Eyster; Peter X Ma
Journal:  Nanomedicine (Lond)       Date:  2016-05-27       Impact factor: 5.307

10.  Bone engineering on the basis of periosteal cells cultured in polymer fleeces.

Authors:  A Redlich; C Perka; O Schultz; R Spitzer; T Häupl; G R Burmester; M Sittinger
Journal:  J Mater Sci Mater Med       Date:  1999-12       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.